• 2020년 11월 2일 오전 00시 ~ 05시 까지 시스템 정기정검을 시행합니다.
    홈페이지 및 TBS 앱 접속이 원활하지 않을 수 있습니다. 불편을 드려 죄송합니다.
  • WHO Advises Against Use Of Remdesivir For COVID-19 Treatment

(Photo: AP-Yonhap News)
(Photo: AP-Yonhap News)
The World Health Organization says the anti-viral drug remdesivir should not be used to treat COVID-19 patients no matter how severe their illness as it has "no important effect" on survival chances.

The United States, the European Union and other countries have granted temporary approval for the drug developed by Gilead Sciences after initial research showed it may shorten recovery time in some patients.

A WHO Guideline Development Group of international experts said Friday there was "no evidence based on currently available data that it does improve patient-important outcomes."

The panel, which published updated guidance in the BMJ medical journal, acknowledged their recommendation does not mean remdesivir has no benefit for patients.

But it advised against administering remdesivir in addition to usual care for the treatment of people hospitalized with the coronavirus based on the latest figures from four international randomized trials involving more than 7,000 patients, costs, and delivery methods.


Please send comments to tbsefmnews@gmail.com / copyright © tbs. Unauthorized redistribution prohibited.

About us

COPYRIGHT 03909 31, Maebongsan-ro, Mapo-gu, Seoul, Korea S-PLEX CENTER | Tel: 082-2-311-5114
Copyright © Since 2020 Seoul Traffic Broadcasting. All Rights Reserved.